Evaluation of the third trimester amniocentesis for fetal karyotyping in women with fear of pregnancy loss;Évaluation de l'amniocentèse au troisième trimestre pour le dépistage des anomalies chromosomiques chez les patientes n'acceptant pas le risque de perte fœtale

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 37, Issue 4, 2008, Pages 385-391

  Picone, O ^a,b,c   Fuchs, F ^c   Senat M V ^c,e   Brisset, S ^a,b,c   Tachdjian, G ^a,b,c   Audibert, F ^d   Fernandez, H ^a,b,c   Frydman, R ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d UNIVERSITY OF MONTREAL   (Canada)

^e BICÊTRE HOSPITAL   (France)

Author keywords

Amniocentesis; Chorioamniotitis; Fetal loss; FISH; Karyotyping; Preterm birth; Preterm premature rupture of membranes; Third trimester

Indexed keywords

ADULT; AMNIOCENTESIS; ARTICLE; BIOCHEMISTRY; CHROMOSOME ABERRATION; DELIVERY; FEMALE; FETUS DISEASE; FETUS KARYOTYPING; FLUORESCENCE IN SITU HYBRIDIZATION; GESTATIONAL AGE; HUMAN; LABOR; MAJOR CLINICAL STUDY; MATERNAL AGE; MULTIPLE PREGNANCY; PARASITOLOGY; PREGNANCY TERMINATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SEROCONVERSION; SPONTANEOUS ABORTION; THIRD TRIMESTER PREGNANCY; TIME SERIES ANALYSIS; ULTRASOUND; KARYOTYPING; MIDDLE AGED; PREGNANCY; PREMATURITY; RISK FACTOR;

ADULT; AMNIOCENTESIS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; KARYOTYPING; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PREMATURE BIRTH; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 44349105442     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgyn.2007.11.030     Document Type: Article

References (23)

1. Wald N.J., Watt H.C., and Hackshaw A.K. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 341 (1999) 461-467
2. Rozenberg P., Bussieres L., Chevret S., Bernard J.P., Malagrida L., Cuckle H., et al. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Am J Obstet Gynecol 195 (2006) 1379-1387
3. Schuchter K., Hafner E., Stangl G., Ogris E., and Philipp K. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population. Ultrasound Obstet Gynecol 18 (2001) 23-25
4. Cuckle H. Integrating antenatal Down's syndrome screening. Curr Opin Obstet Gynecol 13 (2001) 175-181
5. Avgidou K., Papageorghiou A., Bindra R., Spencer K., and Nicolaides K.H. Prospective first-trimester screening for trisomy 21 in 30, 564 pregnancies. Am J Obstet Gynecol 192 (2005) 1761-1767
6. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group. Randomised trial to assess safety and fetal outcome of early and mid trimester amniocentesis. Lancet 351 (1998) 242-247
7. Tabor A., Philip J., Madsen M., Bang J., Obel E.B., and Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1 (1986) 1287-1293
8. Fisk N.M., Fordham K., and Abramsky L. Elective late fetal karyotyping. Br J Obstet Gynaecol 103 (1996) 468-470
9. Shalev J., Meizner I., Rabinerson D., Mashiach R., Peleg D., Orvieto R., et al. Elective cytogenetic amniocentesis in the third trimester for pregnancies with high risk factors. Prenat Diagn 19 (1999) 749-752
10. Piiroinen O., Erkkola R., and Gronroos M. Low-risk amniocentesis in the third trimester under ultrasound control. Eur J Radiol 4 (1984) 309-311
11. Gordon M.C., Narula K., O'Shaughnessy R., and Barth Jr. W.H. Complications of third-trimester amniocentesis using continuous ultrasound guidance. Obstet Gynecol 99 (2002) 255-259
12. Stark C.M., Smith R.S., Lagrandeur R.M., Batton D.G., and Lorenz R.P. Need for urgent delivery after third-trimester amniocentesis. Obstet Gynecol 95 (2000) 48-50
13. Hodor J.G., Poggi S.H., Spong C.Y., Goodwin K.M., Vink J.S., Pezzullo J.C., et al. Risk of third-trimester amniocentesis: a case-control study. Am J Perinatol 23 (2006) 177-180
14. Picone O., Senat M.V., Rosenblatt J., Audibert F.R., Tachdjian G., Frydman R., et al. Fear of pregnancy loss and fetal karyotyping: a place for third trimester amniocentesis?. Fetal Diagn Ther 23 (2008) 30-35
15. Mathews T., and Verma R.S. Enhancement of amniotic fluid cell growth for genetic amniocentesis. Clin Genet 40 (1991) 190-193
16. Enquête périnatale française, 2003 http://www.sante.gouv.fr/htm/dossiers/perinat03/sommaire.htm.
17. Kong C.W., Leung T.N., Leung T.Y., Chan L.W., Sahota D.S., Fung T.Y., et al. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis. Prenat Diagn 26 (2006) 925-930
18. Mungen E., Tutuncu L., Muhcu M., and Yergok Y.Z. Pregnancy outcome following second-trimester amniocentesis: a case-control study. Am J Perinatol 23 (2006) 25-30
19. Audibert F., Dommergues M., Benattar C., Taieb J., Thalabard J.C., and Frydman R. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study. Ultrasound Obstet Gynecol 18 (2001) 26-31
20. Khoshnood B., De Vigan C., Vodovar V., Goujard J., and Goffinet F. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000. BJOG 111 (2004) 485-490
21. Blondel B., Norton J., du Mazaubrun C., and Breart G. Development of the main indicators of perinatal health in metropolitan France between 1995 and 1998. Results of the national perinatal survey. J Gynecol Obstet Biol Reprod 30 (2001) 552-564
22. Leung W.C., Waters J.J., and Chitty L. Prenatal diagnosis by rapid aneuploidy detection and karyotyping: a prospective study of the role of ultrasound in 1589 second-trimester amniocenteses. Prenat Diagn 24 (2004) 790-795
23. Vintzileos A.M., Guzman E.R., Smulian J.C., Yeo L., Scorza W.E., and Knuppel R.A. Down syndrome risk estimation after normal genetic sonography. Am J Obstet Gynecol 187 (2002) 1226-1229